A phase I/II trial of MM-121 in combination with erlotinib in patients (pts) with non-small cell lung cancer (NSCLC).
L. V. Sequist
Research Funding - Merrimack
W. A. Harb
Research Funding - Merrimack
M. Modiano
Research Funding - Merrimack
D. M. Jackman
Consultant or Advisory Role - Foundation Medicine
Research Funding - Merrimack
K. Wong
Research Funding - Merrimack
J. A. Engelman
Research Funding - Merrimack
R. Nering
Employment or Leadership Position - Merrimack
Stock Ownership - Merrimack
M. Onsum
Employment or Leadership Position - Merrimack
Stock Ownership - Merrimack
V. M. Moyo
Employment or Leadership Position - Merrimack
Stock Ownership - Merrimack